Validation of novel grading schemes and refinement of the Leibovich risk groups for chromophobe renal cell carcinoma

被引：0

作者：

Haiyue Lin ^{[1
]}

Caiying Wang ^{[2
]}

Yun Zhao ^{[3
]}

Run Wang ^{[4
]}

Wei Xi ^{[5
]}

Ying Xiong ^{[5
]}

Li Xiao ^{[3
]}

Yi Liu ^{[1
]}

Shaoting Zhang ^{[6
]}

Chenchen Dai ^{[7
]}

机构：

[1] Xuzhou Medical University Affiliated Hospital of Lianyungang,Department of Pathology

[2] Fudan University,Department of Pathology, Zhongshan Hospital

[3] Fudan University,Department of Pathology, Huadong Hospital

[4] Sir Run Run Shaw Hospital,Department of Pathology

[5] Fudan University,Department of Urology, Zhongshan Hospital

[6] Shandong Cancer Hospital and Institute,Department of Radiology

[7] Shandong First Medical University,Department of Radiology, Zhongshan Hospital

[8] Shandong Academy of Medical Sciences,undefined

[9] Fudan University,undefined

来源：

World Journal of Urology | / 43卷 / 1期

关键词：

Chromophobe renal cell carcinoma; Prognosis; Grading schemes; Leibovich risk groups;

D O I：

10.1007/s00345-024-05394-3

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Chromophobe renal cell carcinoma: Can be graded?
Linares Martin, E. M.
Azueta, A.
Velilla, G.
Freire, J.
Garcia Berbel, P.
Pereda Marcos, S.
Dominguez Esteban, M.
Racean, S. F.
Leon del Castillo, A.
Garcia Arranz, P.
Gomez Roman, J.
VIRCHOWS ARCHIV, 2015, 467 : S266 - S266
[42] Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
Lichtbroun, Benjamin J.
Shinder, Brian
Sara, Tina Gowda
Srivastava, Arnav
Saraiya, Biren
Mayer, Tina M.
Cristelli, Ryan
Sadimin, Evita
Weiss, Robert E.
Singer, Eric A.
JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (03): : 1 - 8
[43] Chromophobe renal cell carcinoma with neuroendocrine differentiation
Parada, David D.
Pena, Karla B. G.
APMIS, 2008, 116 (09) : 859 - 865
[44] Pathobiology and prognosis of chromophobe renal cell carcinoma
Klatte, Tobias
Han, Ken-ryu
Said, Jonathan W.
Boehm, Malte
Allhoff, Ernst Peter
Kabbinavar, Fairooz F.
Belldegrun, Arie S.
Pantuck, Allan J.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (06) : 604 - 609
[45] HUMAN CHROMOPHOBE CELL RENAL-CARCINOMA
THOENES, W
STORKEL, S
RUMPELT, HJ
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1985, 48 (03) : 207 - 217
[46] Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
Li, Shuaishuai
Zhu, Jiawei
He, Zhenwei
Ashok, Raj
Xue, Ning
Liu, Zijie
Ding, Li
Zhu, Haitao
FRONTIERS IN ONCOLOGY, 2022, 12
[47] Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study
Wang, Jinkui
Zhanghuang, Chenghao
Tan, Xiaojun
Mi, Tao
Liu, Jiayan
Jin, Liming
Li, Mujie
Zhang, Zhaoxia
He, Dawei
FRONTIERS IN PUBLIC HEALTH, 2022, 10
[48] Rhabdoid differentiation of chromophobe renal cell carcinoma
Shannon, BA
Cohen, RJ
PATHOLOGY, 2003, 35 (03) : 228 - 230
[49] Intravesical recurrence of chromophobe renal cell carcinoma
Kelly, Niall P.
Mclornan, Liza
UROLOGY CASE REPORTS, 2023, 50
[50] Immunohistochemical characteristics of chromophobe cell renal carcinoma
Imura, G
Shimizu, K
Masawa, N
Igarashi, S
Hoshi, K
17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1133 - 1135

← 1 2 3 4 5 →